Advertisement

Management of Antepartum Fetal Death

  • Jeremy Chipchase
  • Donald M. Peebles

Abstract

The death of a fetus in utero is a tragic event irrespective of gestation. The importance of appropriate psychological support for the parents at such a time is well recognised and has been reviewed recently [1]. This chapter will focus on the clinical management of antepartum fetal death from 20 weeks gestation with particular reference to IUGR.

Keywords

Disseminate Intravascular Coagulation Disseminate Intravascular Coagulation Fetal Death Umbilical Artery Fetal Growth Restriction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fox R, Pillai M, Porter J, Gill G. The management of late fetal death: a guide to comprehensive care. Br J Obstet Gynaecol 1998;104–10.Google Scholar
  2. Department of Health. Confidential enquiries into stillbirth and deaths in infancy; 4th Annual Report, 1 January-31 December 1995. London: DoH, 1997.Google Scholar
  3. Hadlock FP, Harrist RB, Martinez-Poyer J. In-utero analysis of fetal growth: a sonographic weight standard. Radiology 1991;181:129–33PubMedGoogle Scholar
  4. Gardosi J, Mul T, Mongelli M, Fagan D. Analysis of birthweight and gestational age in antepartum stillbirths. Br J Obstet Gynaecol 1998;105:524–30.PubMedCrossRefGoogle Scholar
  5. Department of Health. Confidential enquiries into stillbirth and deaths in infancy; 4th Annual Report, 1 January-31 December 1995. London: DoH, 1997.Google Scholar
  6. Guzman ER, Benito CW, Vintizeleos AM, et al. Intrauterine growth restriction prior to 24 weeks of gestation associated with abnormal uterine and umbilical artery Doppler velocimetry [abstract]. J Soc Gynecol Invest 1996;3: 240A.CrossRefGoogle Scholar
  7. Valcamonico A, Danti L, Frusca T, et al. Absent end-diastolic velocity in umbilical artery: risk of neonatal morbidity and brain damage. Am J Obstet Gynecol 1994;170:796–801.PubMedGoogle Scholar
  8. Kingdom JCP, Rodeck CH, Kaufmann R Umbilical artery Doppler — more harm than good? Br J Obstet Gynaecol 1997;104:393–6.PubMedCrossRefGoogle Scholar
  9. Nolan RL. The maternal abdomen and pelvis in pregnancy. In: Sauerbrei EE, Nguyen KT, Nolan RL, editors. A practical guide to ultrasound in obstetrics and gynaecology, 2nd edn. New York: Lippincott-Raven, 1998;503–35.Google Scholar
  10. Kellner KR, Donnelly WH, Gould SD. Parental behaviour after perinatal death: lack of predictive demographic and obstetric variables. Obstet Gynecol 1984;63:809–14.PubMedGoogle Scholar
  11. Weiner AE, Reid DE, Roby CC, Diamond LK. Coagulation defects with intrauterine death from Rh isosensitization. Am J Obstet and Gynaecol 1950;60:1015–21.Google Scholar
  12. Pritchard JA, Ratnoff OD. Studies of fibrinogen and other haemostatic factors in women with intrauterine death and delayed surgery. Surg Gynaecol Obstet 1995;10:467–77.Google Scholar
  13. Pritchard JA. Fetal death in utero. Obstet Gynaecol 14:573–80.Google Scholar
  14. Pritchard JA. Haematological problems associated with delivery, placental abruption, retained dead fetus, and amniotic fluid embolism. Clin Haematol 1973;2(3):563–86.Google Scholar
  15. Baglin T. Disseminated intravascular coagulation: diagnosis and management. BMJ 1996;312: 683–7.PubMedCrossRefGoogle Scholar
  16. Colman R, Robboy S, Minna J. Disseminated intravascular coagulation (DIC): an approach. Am J Med 1972;52;679–87.PubMedCrossRefGoogle Scholar
  17. Seigel T, Seligsohn U, Agahi E, Modan M. Clinical and laboratory aspects of DIC; A study of 118 cases. Thromb Haemost 1978;39:122–34.Google Scholar
  18. Spero J, Lewis J, Hasiba U. Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost 1980;3:28–33.Google Scholar
  19. Carr J, Mckinney M, McDonnagh J. Diagnosis of disseminated intravascular coagulation. Role of D-dimer. Am J Clin Pathol 1989;91:280–7.Google Scholar
  20. Williams E. Disseminated intravascular coagulation. In: Loscalzo J, Schäfer A, editors. Thrombosis and haemorrhage. Boston: Blackwell Science 1994;921–44.Google Scholar
  21. Urquhart DR. Therapeutic abortion; methods used in the second trimester. Curr Obstet Gynaecol 1993;3:17–22.CrossRefGoogle Scholar
  22. Wagatsuma T. Intra amniotic injection of saline for therapeutic abortion. Am J Obstet Gynaecol 1993;93:743–5.Google Scholar
  23. MacDonald D, O’Driscoll MK, Geoghegan FJ. Intra-amniotic dextrose - a maternal death. J Obstet Gynaecol Br Commonwealth 1965;72:452–5.CrossRefGoogle Scholar
  24. Mahomed K, Jayaguru A. Extra amniotic saline infusion for induction of labour in ante-partum fetal death: a cost effective method worthy of wider use. Br J Obstet Gynaecol 1997;104(9): 1058–61.PubMedCrossRefGoogle Scholar
  25. Hill NCW, MacKenzie IZ. 2308 second trimester terminations using extra-amniotic or intra- amniotic prostaglandin E2: an analysis of efficacy and complications. Br J Obstet Gynaecol 1989;96:1421–31.Google Scholar
  26. Sakamoto S, Satoh K, Nishiya I, Kunimoto K, Chimura T, Oda T. Abortifacient effect and uterine cervix—dilating action of 16,16—dimethyl—trans—delta2 PGE 1 methylester(0N0802) in the form of a vaginal suppository (a randomized double-blind controlled study in the second trimester of pregnancy). Prostaglandins Leukotrienes 1982;9:349–61.CrossRefGoogle Scholar
  27. Thong KJ, Robertson AJ, Baird DT. Retrospective study of 932 second trimester terminations using gemeprost (16,16 dimethyl-trans PGE1 methyl ester). Prostaglandins 1992;44:65–74.PubMedCrossRefGoogle Scholar
  28. Urquhart DR, Templeton AA. Mifepristone and second trimester pregnancy Lancet 1987;ii: 1405.Google Scholar
  29. Roger MW, Baird DT. Pretreatment with mifepristone (RU486) reduces the interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 1990;97:41–5.CrossRefGoogle Scholar
  30. Aubeny E, Baulieu EE. Activité contragestive de 1 association auRU486 d'une Prostaglandine active par voie orale. CR Acad Sci III 1991;312:539–45.Google Scholar
  31. El-Refaey H, Hinshaw K, Templeton A. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone(RU486). Hum Reprod 1993;8(10):1744–6.Google Scholar
  32. El-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod 1995;10(2):475–8.PubMedGoogle Scholar
  33. Bugalho A, Bique C, Almeidia L, Faundes A. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann 1993;24:319–23.PubMedCrossRefGoogle Scholar
  34. Marguilies M, Perez MC, Vato L. Misoprostol to induce labour. Lancet 1992;339:64.CrossRefGoogle Scholar
  35. Report on confidential enquiries into maternal deaths in England and Wales. HMSO, 1997.Google Scholar
  36. Enborm JA. Twin pregnancy with intrauterine death of one twin. Am J Obstet Gynaecol 1985;152:429–9.Google Scholar
  37. D'Alton ME, Newton ER, Cetrulo A. Intrauterine fetal demise in multiple gestation. Acta Genet Med Gemellol 1984;33:43–9.PubMedGoogle Scholar
  38. Murphy K. Intrauterine death in a twin: implications for the survivor. In: Ward RH, Whittle M, editors. Multiple pregnancy. London: RCOG Press, 1995.Google Scholar
  39. Pinette MG, Pan Y, Pinette SG, Stubblefield PG. Treatment of twin–to–twin transfusion syndrome. Obstet Gynecol 1993;82:841–6.PubMedGoogle Scholar
  40. Trespidi L, Boschetto C, Caravelli E, Villa L, Kustermann A, Nicolini U. Serial amniocentesis in the management of twin—to—twin transfusion syndrome: when is it valuable? Fetal Diagn Ther 1997;12:15–20.PubMedGoogle Scholar
  41. Dippel AL. Bull Johns Hopkins Hosp 1934;54:24.Google Scholar
  42. Brenner B, Blumfield Z. Thrombophilia and fetal loss. Blood Rev. 1997; 11:72–9.PubMedCrossRefGoogle Scholar
  43. Salafia CM, Ernst LM, Pezz. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol 1995;12(2):106–10.Google Scholar
  44. Allen MC. Developmental outcome and follow-up of the small for gestational age infant. Semin Perinatol 1984;8:123–9.PubMedGoogle Scholar
  45. Taylor DI. Low birth weight and neurodevelopmental handicap. Clin Obstet Gynecol 1984;11:525–31.Google Scholar
  46. Katano K, Aoki A, Sasa H, Ogasawara M, Matsuura E, Yagami Y. Beta 2-glycoprotein I—independent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996;11:509–12.PubMedGoogle Scholar
  47. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993;100:909–13.PubMedCrossRefGoogle Scholar
  48. Draycott TJ, Kaloo P, Locke R, Fox R, Smith P, Read M. A case—control study of anticardiolipin antibodies after unexplained fetal loss from 24 weeks of gestation(abstract). Br J Obstet Gynaecol 1996;103:484.Google Scholar
  49. Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, von Blomberg BME, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042–8.PubMedCrossRefGoogle Scholar
  50. Preston FE, Rosendale FR, Walker ID. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913–16.PubMedCrossRefGoogle Scholar
  51. Sanson BJ, Friederich PW, Simioni P. The risk of abortion and stillbirth in anti—thrombic—protein C-and protein S-deficient women. Thromb Haemost 1996;75:387–8.PubMedGoogle Scholar
  52. Maternal and Neonatal Haemostasis Working Party. Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. J Clin Pathol 1993;46:489–96.CrossRefGoogle Scholar
  53. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H. Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature 1994;369:64–7.PubMedCrossRefGoogle Scholar
  54. Waters. UK Collaborative Study: Solid tissue culture in clinical cytogenetics. Association Clinical Cytogeneticists Working Party Report.Google Scholar
  55. Thornton CM, O’Hara MD. A regional audit of perinatal and infant autopsies in Northern Ireland. Br J Obstet Gynecol 1998;105:18–23.CrossRefGoogle Scholar
  56. Weston MJ, Porter HJ, Andrews HS, Berry PJ. Correlation of antenatal ultrasonography and pathological examination in 153 malformed fetuses. J Clin Ultrasound 1993;21:387–92.PubMedCrossRefGoogle Scholar
  57. Joint Working Party of the Royal College of Pathologists and Royal College of Obstetricians and Gynaecologists. Report on fetal and perinatal pathology. London: Royal College of Obstetricians and Gynaecologists, 1988.Google Scholar
  58. Royal College of Pathologists. Guidelines for post mortem reports. London: Royal College of Pathologists, 1993.Google Scholar
  59. Rushton DI. West Midlands perinatal mortality survey: an audit of 300 perinatal autopsies. Br J Obstet Gynaecol 1991;98:624–7.PubMedCrossRefGoogle Scholar
  60. El-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod 1995;10(2):475–8.PubMedGoogle Scholar
  61. Bugalho A, Bique C, Almeidia L, Faundes A. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann 1993;24:319–23.PubMedCrossRefGoogle Scholar
  62. Marguilies M, Perez MC, Vato L. Misoprostol to induce labour. Lancet 1992;339:64.CrossRefGoogle Scholar
  63. Report on confidential enquiries into maternal deaths in England and Wales. HMSO, 1997.Google Scholar
  64. Enborm JA. Twin pregnancy with intrauterine death of one twin. Am J Obstet Gynaecol 1985;152:429–9.Google Scholar
  65. D’Alton ME, Newton ER, Cetrulo A. Intrauterine fetal demise in multiple gestation. Acta Genet Med Gemellol 1984;33:43–9.PubMedGoogle Scholar
  66. Murphy K. Intrauterine death in a twin: implications for the survivor. In: Ward RH, Whittle M, editors. Multiple pregnancy. London: RCOG Press, 1995.Google Scholar
  67. Pinette MG, Pan Y, Pinette SG, Stubblefield PG. Treatment of twin-to-twin transfusion syndrome. Obstet Gynecol 1993;82:841–6.PubMedGoogle Scholar
  68. Trespidi L, Boschetto C, Caravelli E, Villa L, Kustermann A, Nicolini U. Serial amniocentesis in the management of twin-to-twin transfusion syndrome: when is it valuable? Fetal Diagn Ther 1997;12:15–20.PubMedGoogle Scholar
  69. Dippel AL. Bull Johns Hopkins Hosp 1934;54:24.Google Scholar
  70. Brenner B, Blumfield Z. Thrombophilia and fetal loss. Blood Rev. 1997; 11:72–9.PubMedCrossRefGoogle Scholar
  71. Salafia CM, Ernst LM, Pezz. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol 1995;12(2):106–10.Google Scholar
  72. Allen MC. Developmental outcome and follow-up of the small for gestational age infant. Semin Perinatol 1984;8:123–9.PubMedGoogle Scholar
  73. Taylor DI. Low birth weight and neurodevelopmental handicap. Clin Obstet Gynecol 1984;11:525–31.Google Scholar
  74. Katano K, Aoki A, Sasa H, Ogasawara M, Matsuura E, Yagami Y. Beta 2-glycoprotein I-independent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996;11:509–12.PubMedGoogle Scholar
  75. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993;100:909–13.PubMedCrossRefGoogle Scholar
  76. Draycott TJ, Kaloo P, Locke R, Fox R, Smith P, Read M. A case-control study of anticardiolipin antibodies after unexplained fetal loss from 24 weeks of gestation(abstract). Br J Obstet Gynaecol 1996;103:484.Google Scholar
  77. Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, von Blomberg BME, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042–8.PubMedCrossRefGoogle Scholar
  78. Preston FE, Rosendale FR, Walker ID. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913–16.PubMedCrossRefGoogle Scholar
  79. Sanson BJ, Friederich PW, Simioni P. The risk of abortion and stillbirth in anti-thrombic-protein C-and protein S-deficient women. Thromb Haemost 1996;75:387–8.PubMedGoogle Scholar
  80. Maternal and Neonatal Haemostasis Working Party. Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. J Clin Pathol 1993;46:489–96.CrossRefGoogle Scholar
  81. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H. Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature 1994;369:64–7.PubMedCrossRefGoogle Scholar
  82. Waters. UK Collaborative Study: Solid tissue culture in clinical cytogenetics. Association Clinical Cytogeneticists Working Party Report.Google Scholar
  83. Thornton CM, O’Hara MD. A regional audit of perinatal and infant autopsies in Northern Ireland. Br J Obstet Gynecol 1998;105:18–23.CrossRefGoogle Scholar
  84. Weston MJ, Porter HJ, Andrews HS, Berry PJ. Correlation of antenatal ultrasonography and pathological examination in 153 malformed fetuses. J Clin Ultrasound 1993;21:387–92.PubMedCrossRefGoogle Scholar
  85. Joint Working Party of the Royal College of Pathologists and Royal College of Obstetricians and Gynaecologists. Report on fetal and perinatal pathology. London: Royal College of Obstetricians and Gynaecologists, 1988.Google Scholar
  86. Royal College of Pathologists. Guidelines for post mortem reports. London: Royal College of Pathologists, 1993.Google Scholar
  87. Rushton DI. West Midlands perinatal mortality survey: an audit of 300 perinatal autopsies. Br J Obstet Gynaecol 1991;98:624–7.PubMedCrossRefGoogle Scholar
  88. Wright C, Cameron H, Lamb W. A study of the of perinatal autopsy in the former Northern region. Br J Obstet Gynaecol 1998;105:24–8.PubMedCrossRefGoogle Scholar
  89. Fox H. The placenta in intrauterine growth retardation: Ward RHT, Smith SK, Donnai D, editors. Early fetal growth and development. London: RCOG press, 1994;23–44.Google Scholar
  90. Fox H. Non-trophoblastic tumours of the placenta. In: Fox, editor. Obstetrical and gynaecological pathology, 3rd edn. Edinburgh, Churchill Livingstone, 1030–44.Google Scholar
  91. Salafia CM, Vintzileos AM, Silberman L. Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol 1992;9:179–84.PubMedCrossRefGoogle Scholar
  92. Stioui S, de Silvestris M, Molinari A. Trisomie 22 placenta in a case of severe intrauterine growth retardation. Prenat Diagn 1989;9:673–6.PubMedCrossRefGoogle Scholar
  93. Schwinger B, Seidl B, Klink F. Chromosome mosaicism of the placenta—a cause of development failure of the fetus? Prenat Diagn 1989;9:639–47.PubMedCrossRefGoogle Scholar
  94. Giles WB, Trudinger BJ, Baird PJ. Fetal umbilical artery flow velocity wavelengths and placental resistance: pathological correlation. Br J Obstet Gynaecol 1985;92:31–8.PubMedCrossRefGoogle Scholar
  95. Jackson MR, Walsh AJ, Morrow RJ, Mullen JBM, Lye SJ, Knox-Ritchie JW. Reduced placental villous tree elaboration in small-for-gestational age pregnancies: relationship with umbilical artery Doppler waveforms. Am J Obstet Gynecol 1995;172:518–25.PubMedCrossRefGoogle Scholar
  96. Krebs C, Macara LM, Leiser R, Bowman AWF, Greer IA, Kingdom JCP. Intrauterine growth restriction with absent end—diastolic flow velocity in the umbilical artery is associated with maldevelopment of the terminal placental villous tree. Am J Obstet Gynecol 1996;175:1534–42.PubMedCrossRefGoogle Scholar
  97. Rains CP, Bryson HM, Fitton A. Cabergoline. Drugs 1995;49:255–79.PubMedCrossRefGoogle Scholar
  98. Iffy L. Lethal cardiovascular complications in patients receiving bromocriptine for ablactation. Medical law 1995;14:99–104.Google Scholar
  99. Kuno N, Itakura A, Kurachi O, Mizutani S, Kazeto S, Tomoda Y. Decrease in severity of intrauterine growth retardation in subsequent pregnancies. Int J Gynaecol Obstet 1995;51:219–24.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2000

Authors and Affiliations

  • Jeremy Chipchase
  • Donald M. Peebles

There are no affiliations available

Personalised recommendations